BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16920102)

  • 21. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients.
    Hutchison WD; Lozano AM; Davis KD; Saint-Cyr JA; Lang AE; Dostrovsky JO
    Neuroreport; 1994 Jul; 5(12):1533-7. PubMed ID: 7948856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuronal activity in the globus pallidus internus in parkinsonian patients with rigidity and bradykinesia].
    Xu CP; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1022-6. PubMed ID: 18754433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single unit "pauser" characteristics of the globus pallidus pars externa distinguish primary dystonia from secondary dystonia and Parkinson's disease.
    Sani S; Ostrem JL; Shimamoto S; Levesque N; Starr PA
    Exp Neurol; 2009 Apr; 216(2):295-9. PubMed ID: 19146856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stn-dbs activates the target area in Parkinson disease.
    Montgomery EB; Hilker R
    Neurology; 2009 Jul; 73(4):327; author reply 327-8. PubMed ID: 19636056
    [No Abstract]   [Full Text] [Related]  

  • 25. [Method of localization of microelectrode in the globus pallidus during pallidotomy for Parkinson's disease].
    Liu X; Wang H; Qian Z; Yang T; Gu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):488-91. PubMed ID: 17713245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internal pallidal neuronal activity during mild drug-related dyskinesias in Parkinson's disease: decreased firing rates and altered firing patterns.
    Lee JI; Verhagen Metman L; Ohara S; Dougherty PM; Kim JH; Lenz FA
    J Neurophysiol; 2007 Apr; 97(4):2627-41. PubMed ID: 17215512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The second brain and Parkinson's disease.
    Lebouvier T; Chaumette T; Paillusson S; Duyckaerts C; Bruley des Varannes S; Neunlist M; Derkinderen P
    Eur J Neurosci; 2009 Sep; 30(5):735-41. PubMed ID: 19712093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes to interneuron-driven striatal microcircuits in a rat model of Parkinson's disease.
    Salin P; López IP; Kachidian P; Barroso-Chinea P; Rico AJ; Gómez-Bautista V; Coulon P; Kerkerian-Le Goff L; Lanciego JL
    Neurobiol Dis; 2009 Jun; 34(3):545-52. PubMed ID: 19341798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats.
    Cui QL; Yung WH; Chen L
    Neurosci Res; 2008 Feb; 60(2):162-9. PubMed ID: 18054402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage-dependent patterns of disturbed neural synchrony in Parkinson's disease.
    Berendse HW; Stam CJ
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S440-5. PubMed ID: 18267280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional anatomy of the pallidal base in Parkinson's disease.
    Taha JM; Favre J; Baumann TK; Burchiel KJ
    Neurosurgery; 1996 Dec; 39(6):1164-7; discussion 1167-8. PubMed ID: 8938771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathology of Parkinson's disease.
    Jellinger KA
    Adv Neurol; 2001; 86():55-72. PubMed ID: 11554010
    [No Abstract]   [Full Text] [Related]  

  • 34. Indirect-pathway neurons lose their spines in Parkinson disease.
    Gerfen CR
    Nat Neurosci; 2006 Feb; 9(2):157-8. PubMed ID: 16439979
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of the medial pallidum in the pathophysiology of akinesia in primates.
    Percheron G; Filion M; Tremblay L; Fénelon G; François C; Yelnik J
    Adv Neurol; 1993; 60():84-7. PubMed ID: 8420221
    [No Abstract]   [Full Text] [Related]  

  • 36. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parkinson revisited: pathophysiology of motor signs.
    Hallett M
    Adv Neurol; 2003; 91():19-28. PubMed ID: 12442661
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic electrical stimulation of the globus pallidus for treatment of Parkinson's disease].
    Ogura M; Tanaka S; Nishibayashi H; Itakura T
    No Shinkei Geka; 2004 Jul; 32(7):763-72. PubMed ID: 15462368
    [No Abstract]   [Full Text] [Related]  

  • 39. Fractal characteristics of human Parkinsonian neuronal spike trains.
    Rasouli G; Rasouli M; Lenz FA; Verhagen L; Borrett DS; Kwan HC
    Neuroscience; 2006; 139(3):1153-8. PubMed ID: 16515843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caenorhabditis elegans as a model system for Parkinson's disease.
    Schmidt E; Seifert M; Baumeister R
    Neurodegener Dis; 2007; 4(2-3):199-217. PubMed ID: 17596715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.